M.C. Cox

机构：Northwestern University, Northwestern Medicine · ORCID：0000-0002-9260-1799

发表论文 53 篇 · 总被引 603 次 · h-index 10

代表论文

• A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome (2013 · European Journal of Cancer · 被引 159)
• Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study (2019 · Annals of Oncology · 被引 154)
• Larotrectinib efficacy and safety in TRK fusion cancer: An expanded clinical dataset showing consistency in an age and tumor agnostic approach (2018 · Annals of Oncology · 被引 45)
• Rapid, complete and sustained tumour response to the TRK inhibitor larotrectinib in an infant with recurrent, chemotherapy-refractory infantile fibrosarcoma carrying the characteristic ETV6-NTRK3 gene fusion (2019 · Annals of Oncology · 被引 39)
• Prospective Evaluation of Circulating Tumor DNA Using Next-generation Sequencing as a Biomarker During Neoadjuvant Chemotherapy in Localized Pancreatic Cancer (2024 · Annals of Surgery · 被引 24)
• Mutant KRAS in Circulating Tumor DNA as a Biomarker in Localized Pancreatic Cancer Patients Treated With Neoadjuvant Chemotherapy (2024 · Annals of Surgery · 被引 18)